By accessing the Hybrinomics LIMS web platform or installing the Hybrinomics LIMS Android application ("the Service"), you agree to these Terms. If you do not agree, do not use the Service.
The Service is published by Hybrinomics Medical Innovations Pvt Ltd (HMI) and operated for the diagnostic laboratory client whose tenant you log into — primarily Hybrinomics Life Science & Diagnostics LLP (HLD).
You agree not to:
The Service is laboratory workflow and information-management software. It is not a medical device, does not provide diagnoses, and does not replace clinical judgment. Diagnostic conclusions are issued by qualified registered pathologists at the operating laboratory. The Service does not interpret images or biomarkers autonomously for treatment decisions.
All software, design, and content of the Service are owned by HMI and/or its licensors. Limited, revocable, non-transferable license to use the Service is granted for the duration of your authorised access. Patient and operational data entered by the laboratory remain the property of the laboratory and the data principals.
The Service is provided "as is." We aim for high availability but do not guarantee uninterrupted access. Maintenance windows may be scheduled. We are not liable for losses arising from temporary unavailability.
Your privacy is governed by our Privacy Policy, which forms part of these Terms.
HMI / HLD may suspend or terminate your access for breach of these Terms, suspected fraud, or as required by law. On termination, your right to use the Service ends; data retention follows the Privacy Policy.
To the maximum extent permitted by Indian law, HMI's aggregate liability arising out of these Terms shall not exceed the fees you paid for the Service in the twelve months preceding the claim. We are not liable for indirect, incidental, or consequential damages.
These Terms are governed by the laws of India. Disputes are subject to the exclusive jurisdiction of courts in Bangalore, Karnataka.
We may update these Terms. Material changes will be notified on this page and (for app users) at next sign-in. Continued use after the effective date constitutes acceptance.
Questions? Write to support@hybrinomics.com for the software/app, or hld@hybrinomics.com for laboratory matters.